MedTrace Logo

Implementation of Real-time ADE Surveillance and Decision Support

NCT00780572 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 595

Last updated 2015-12-21

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if an electronic alerting technology improves time to intervention for possible ADEs, identify what factors affect adoption of ADE alerts, and whether there is a cost benefit associated with the alerting technology.

Conditions

  • Adverse Drug Events

Interventions

BEHAVIORAL

ADE alert assistant

A note in CPRS alerting providers that patients are at risk for an adverse event based on prescription and lab value histories.

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Jonathan R. Nebeker, MD MS · VA Health Care Salt Lake City

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-09-30
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00780572 on ClinicalTrials.gov